CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 10 enrolled
Drug / intervention
FLASH Radiotherapyradiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04592887
NCT04592887N/ACompleted
CompareCT.gov

Feasibility Study of FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases

Varian, a Siemens Healthineers Company·interventional·Posted Oct 19, 2020·Updated Jul 31, 2024

In Brief

A clinical study evaluating FLASH Radiotherapy for Bone Metastasis. Completed, enrolled 10 participants across 1 site.

Detailed Summary

This purpose of this study is to assess the feasibility of FLASH radiotherapy for the palliative treatment of painful bone metastases. FLASH radiotherapy is radiation treatment delivered at ultra-high dose rates compared to conventional radiation treatment.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBone Metastasis
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedOct 19, 2020
Enrollment StartNov 3, 2020
Primary CompletionMar 27, 2023
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 5.7 years ago

Interventions

FLASH Radiotherapyradiation

FLASH radiotherapy is radiation treatment delivered at ultra-high dose rates compared to conventional radiation treatment.